UROwebinar: Update on the EAU ASCO testicular cancer guidelines

UROwebinar: Update on the EAU ASCO testicular cancer guidelines

01:19:19 |

Related Videos

UROwebinar: Everything you wanted to know about TURBT: How to handle peculiar situations in TURB

59:04

UROwebinar: Everything you wanted to know about TURBT: How to handle peculiar situations in TURB

UROwebinar: How to overcome individual challenges in contemporary BPO management

1:00:20

UROwebinar: How to overcome individual challenges in contemporary BPO management

UROwebinar: Handling adverse events after intravesical instillations in NMIBC

59:49

UROwebinar: Handling adverse events after intravesical instillations in NMIBC

UROwebinar: Stone dust: What is it and how do lasers compare with each other?

1:17:13

UROwebinar: Stone dust: What is it and how do lasers compare with each other?

Dr. Joan Palou about the European School of Urology (ESU)

3:13

Dr. Joan Palou about the European School of Urology (ESU)

UROwebinar: Can PSMA PET/CT spare extended pelvic lymph node dissection in high-risk prostate cancer

1:02:03

UROwebinar: Can PSMA PET/CT spare extended pelvic lymph node dissection in high-risk prostate cancer

Management of Paediatric Urolithiasis - European School of Urology

1:03:54

Management of Paediatric Urolithiasis - European School of Urology

UROwebinar: Basic principles of laparoscopy in paediatric urology

1:05:58

UROwebinar: Basic principles of laparoscopy in paediatric urology

UROwebinar: Partial nephrectomy: What's new about available approaches?

1:16:50

UROwebinar: Partial nephrectomy: What's new about available approaches?

UROWebinar: How to get the best from your modern endourological armamentarium

56:54

UROWebinar: How to get the best from your modern endourological armamentarium

UROwebinar: Infections, antimicrobial stewardship and PCa detection: TP vs TRUS prostate biopsy

1:01:24

UROwebinar: Infections, antimicrobial stewardship and PCa detection: TP vs TRUS prostate biopsy

UROwebinar: Adverse events and toxicity management of mPCa patients from an MDT perspective

58:26

UROwebinar: Adverse events and toxicity management of mPCa patients from an MDT perspective

UROWebinar: Benign Prostatic Obstruction BPO: to prolong medical therapy or to move to MIST?

1:08:22

UROWebinar: Benign Prostatic Obstruction BPO: to prolong medical therapy or to move to MIST?

UROwebinar: Male infertility: An updated work-up

1:08:13

UROwebinar: Male infertility: An updated work-up

UROwebinar: Administration of hormones in infertile males: Indications, EAU Guidelines, expectations

1:00:18

UROwebinar: Administration of hormones in infertile males: Indications, EAU Guidelines, expectations

UROWebinar: Update on novel imaging for non-invasive histological characterization of renal masses

1:01:59

UROWebinar: Update on novel imaging for non-invasive histological characterization of renal masses

UROWebinar: Male hypogonadism: Testosterone therapy is not dangerous

1:02:54

UROWebinar: Male hypogonadism: Testosterone therapy is not dangerous

UROwebinar: Update on the EAU ASCO testicular cancer guidelines

1:19:20

UROwebinar: Update on the EAU ASCO testicular cancer guidelines

UROwebinar: Mastering effective communication and presentation skills

1:12:05

UROwebinar: Mastering effective communication and presentation skills

UROWebinar: From molecular environment to theranostics in hormone sensitive prostate cance

1:09:59

UROWebinar: From molecular environment to theranostics in hormone sensitive prostate cance